PE78899A1 - COMPOSITION OF 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] THIAZOLIDIN-2,4-DIONA - Google Patents

COMPOSITION OF 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] THIAZOLIDIN-2,4-DIONA

Info

Publication number
PE78899A1
PE78899A1 PE1998000466A PE00046698A PE78899A1 PE 78899 A1 PE78899 A1 PE 78899A1 PE 1998000466 A PE1998000466 A PE 1998000466A PE 00046698 A PE00046698 A PE 00046698A PE 78899 A1 PE78899 A1 PE 78899A1
Authority
PE
Peru
Prior art keywords
piridil
etoxi
bencil
diona
thiazolidin
Prior art date
Application number
PE1998000466A
Other languages
Spanish (es)
Inventor
Hamish Ross
Robin Price
Jeffrey Roger Granett
Jaikrishna Patel
Paul Nigel Wray
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc
Publication of PE78899A1 publication Critical patent/PE78899A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

CARACTERIZADA PORQUE COMPRENDE UN COMPUESTO 5-[4-[2-(N-METIL-N-(2-PIRIDIL)AMINO)ETOXI]BENCIL]TIAZOLIDIN-2,4-DIONA DE 2 A 12 mg O COMO UNA SAL DE MALEATO. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION QUE COMPRENDE LA MEZCLA DEL COMPUESTO CON UN PRIMER VEHICULO, LUEGO MEZCLAR CON UN SEGUNDO VEHICULO. TAMBIEN SE REFIERE A UNA COMPOSICION QUE COMPRENDE EL COMPUESTO, SAL SODICA DE GLICOLATO DE ALMIDON, HIDROXIPROPILMETILCELULOSA 2910, CELULOSA MICRO-CRISTALINA Y LACTOSA MONOHIDRATADACHARACTERIZED BECAUSE IT INCLUDES A COMPOUND 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] THIAZOLIDIN-2,4-DIONA FROM 2 TO 12 mg OR AS A MALEATE SALT. IT ALSO REFERS TO A PREPARATION PROCEDURE WHICH INCLUDES THE MIXTURE OF THE COMPOUND WITH A FIRST VEHICLE, THEN MIX WITH A SECOND VEHICLE. ALSO REFERS TO A COMPOSITION THAT INCLUDES THE COMPOUND, SODIUM SALT OF STARCH GLYCOLATE, HYDROXYPROPYL METHYL CELLULOSE 2910, MICRO-CRYSTALLINE CELLULOSE AND MONOHYDRATED LACTOSE

PE1998000466A 1997-06-05 1998-06-05 COMPOSITION OF 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] THIAZOLIDIN-2,4-DIONA PE78899A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711683.4A GB9711683D0 (en) 1997-06-05 1997-06-05 Composition
GBGB9712851.6A GB9712851D0 (en) 1997-06-18 1997-06-18 Composition

Publications (1)

Publication Number Publication Date
PE78899A1 true PE78899A1 (en) 1999-10-22

Family

ID=26311662

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000466A PE78899A1 (en) 1997-06-05 1998-06-05 COMPOSITION OF 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] THIAZOLIDIN-2,4-DIONA

Country Status (29)

Country Link
EP (1) EP0998284A1 (en)
JP (1) JP2001521553A (en)
KR (1) KR20010013410A (en)
CN (3) CN1112926C (en)
AP (1) AP1214A (en)
AR (2) AR008198A1 (en)
AU (1) AU8215098A (en)
BG (1) BG104048A (en)
BR (1) BR9810405A (en)
CA (2) CA2333352A1 (en)
CO (1) CO4940400A1 (en)
DZ (1) DZ2510A1 (en)
EA (1) EA002384B1 (en)
GB (1) GB9711683D0 (en)
HU (1) HUP0004070A3 (en)
ID (1) ID24264A (en)
IL (1) IL133074A0 (en)
MX (1) MXPA99011322A (en)
NO (2) NO995938L (en)
NZ (2) NZ523725A (en)
OA (1) OA11306A (en)
PE (1) PE78899A1 (en)
PL (1) PL337201A1 (en)
SK (1) SK164899A3 (en)
TR (2) TR200002790T2 (en)
TW (1) TW570797B (en)
UY (1) UY25032A1 (en)
WO (1) WO1998055122A1 (en)
ZA (2) ZA984826B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
PL351684A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
WO2000064892A2 (en) 1999-04-23 2000-11-02 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB0021978D0 (en) 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
GB0127805D0 (en) * 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129871D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
ES2294980T1 (en) * 2006-05-09 2008-04-16 Teva Pharmaceutical Industries Ltd. ACID 2-N- (5 - ((4- (2- (METHYL-2-PYRIDINYLAMINE) ETHOXY) PHENYL) METHYL) -2,4-THIAZOLIDINDIONA) -BUTANODIOIC, PREPARATION PROCEDURES AND COMPOSITIONS WITH ROSIGLITAZONA MALEATE.
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (en) * 2013-07-17 2015-01-22 Glenmark Pharmaceuticals S.A. Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (en) * 1987-09-04 2000-05-11 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
WO1995021608A1 (en) * 1994-02-10 1995-08-17 Smithkline Beecham Plc Use of insulin sensitisers for treating renal diseases
NZ313874A (en) * 1995-08-10 2000-09-29 Warner Lambert Co Compounds used as medicaments useful in eliminating the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
AU7604596A (en) * 1995-11-17 1997-06-11 Warner-Lambert Company A method of treating myotonic dystrophy
NZ314406A (en) * 1996-03-18 2000-12-22 Sankyo Co Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
CA2260044A1 (en) * 1996-07-12 1998-01-22 Stephen Alistair Smith Novel treatment of leptine resistance

Also Published As

Publication number Publication date
EA002384B1 (en) 2002-04-25
EA199901116A1 (en) 2000-06-26
JP2001521553A (en) 2001-11-06
CN1259050A (en) 2000-07-05
AP9901696A0 (en) 1999-12-31
CN1112926C (en) 2003-07-02
ZA984826B (en) 1999-08-03
TW570797B (en) 2004-01-11
NZ513922A (en) 2001-09-28
TR199902963T2 (en) 2000-02-21
CO4940400A1 (en) 2000-07-24
ZA9811572B (en) 1999-07-22
SK164899A3 (en) 2000-11-07
BG104048A (en) 2000-07-31
CA2333352A1 (en) 1998-12-10
NZ523725A (en) 2004-09-24
HUP0004070A3 (en) 2002-03-28
NO995938D0 (en) 1999-12-03
NO20040738L (en) 2000-02-02
AR015120A1 (en) 2001-04-18
HUP0004070A2 (en) 2002-02-28
NO995938L (en) 2000-02-02
TR200002790T2 (en) 2001-11-21
CA2292629A1 (en) 1998-12-10
CN1430959A (en) 2003-07-23
CA2292629C (en) 2004-01-06
AR008198A1 (en) 1999-12-29
BR9810405A (en) 2000-08-29
ID24264A (en) 2000-07-13
OA11306A (en) 2003-10-22
UY25032A1 (en) 1998-11-26
IL133074A0 (en) 2001-03-19
MXPA99011322A (en) 2004-12-02
AU8215098A (en) 1998-12-21
AP1214A (en) 2003-10-08
DZ2510A1 (en) 2003-01-25
PL337201A1 (en) 2000-08-14
CN1526391A (en) 2004-09-08
KR20010013410A (en) 2001-02-26
EP0998284A1 (en) 2000-05-10
WO1998055122A1 (en) 1998-12-10
GB9711683D0 (en) 1997-08-06

Similar Documents

Publication Publication Date Title
PE78899A1 (en) COMPOSITION OF 5- [4- [2- (N-METHYL-N- (2-PIRIDIL) AMINO) ETOXI] BENCIL] THIAZOLIDIN-2,4-DIONA
EA200601145A1 (en) TABLET OF SLOW-DIVISION OF INSULIN SENSITIZER AND OTHER ANTI-DIABETIC AGENTS
TR200001880T2 (en) The compound and method of an oral preparation of itraconazole.
PE20000550A1 (en) COMPOSITION OF A BENZIMIDAZOLE DERIVATIVE USEFUL AS ANTI-VIRAL AND ANTI-HIV
MA30598B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING TETRAHYDROFOLIC ACID.
AR057970A2 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MELLITUS DIABETES AND CONDITIONS ASSOCIATED WITH MELLITUS DIABETES AND PROCEDURES TO PREPARE SUCH COMPOSITIONS
ES2165833T1 (en) ENTERIC COVERED PHARMACEUTICAL COMPOSITION AND MANUFACTURING PROCEDURE.
EP1106210A3 (en) Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications
EA199901100A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ELETRIPTAN HEMISULPHATE AND CAFFEINE
DE69803750T2 (en) THIAZOLIDINEDIONE AND OXAZOLIDINEDIONE DERIVATIVES WITH ANTIDIABETIC, HYPOLIPIDEMIC AND ANTI-HYPERTENSIVE PROPERTIES
JO2239B1 (en) Process for the preparation of benzothiophene derivatives
PE20061373A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 'N- (2-CHLORO-6-METHYLPHENIL) -2 - [[6- [4- (2-HYDROXYETHYL) -1-PIPERAZINYL] -2-METHYL-4-PYRIMIDINYL] AMINO] -5- THIAZOLCARBOXAMIDE
BR0111868A (en) Pharmaceutical Compositions
ES2188766T3 (en) PHARMACEUTICAL COMPOSITION CONTAINING LAMOTRIGINE.
EA200702648A1 (en) PHARMACEUTICAL COMPOSITION, SUITABLE FOR INTRODUCTION ONCE A DAY
TR200002543T2 (en) Pharmaceutical compositions containing phospholipase inhibitor sodium [[3- (2-amino-1,2-dioxyethyl-1-phenylmethyl) -2-ethyl-1-phenylmethyl) - 1H-indol-4-yl] oxy] acetate
DK0842165T3 (en) Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
ID27649A (en) PAPER MAKING PROCESS
DE69819742D1 (en) INDOLDER DERIVATIVES AS 5-HT1B AND 5-HT1D AGONISTS
PE61699A1 (en) PHARMACEUTICAL COMPOSITION OF LAMIVUDINE
PE108199A1 (en) PHARMACEUTICAL COMPOSITION OF TIAZOLIDINDIONA AND SULFONILUREA
AR051727A1 (en) ORAL IMMEDIATE RELEASE FORMULATION OF A LOW SOLUBLE ACTIVE SUBSTANCE IN WATER
UY25051A1 (en) COMPOSITIONS FOR THE TREATMENT OF DIABETES MELLITUS
TR200002293T2 (en) Pharmaceutical compositions.
HK1047228A1 (en) Endoparasiticidal agents

Legal Events

Date Code Title Description
FC Refusal